Green light, or go slow: What FDA's new draft guidance means for social media in pharma

Share this article:

Click here to register 

Date: Thursday, March 13, 2014
Time: 2:00 PM ET / 11:00 AM PT

While not the last word on the subject, the agency's latest social media guidance was a good step forward. This informative webcast is designed to dissect the guidance and help brand directors and communication managers, whether currently engaging in social media or looking to do so, apply the rules now.

Experts from pharma marketing and digital media will leverage real scenarios to provide insights on the draft guidance, as the agency seeks to modernize its regulations for social and offer ways for pharma to communicate in the medium.

The event will explain the impact in the following areas:

-Handling of user-generated content

-Influence over third-party content

-New rules on submission of real-time content

-Responsibilities of those acting on the company's behalf

-Practicalities surrounding social media workflow

-Impact on expectations from consumers and HCPs

-What's next

Sponsored by: 

Share this article:

Email Newsletters

More in Webcasts

Delighting Your Customer through Multichannel Customer Engagement

Today's life sciences customers expect service delivered on their terms. They want the convenience of email, phone, web, and face-to-face - all personalized, all coordinated. The typical experience they receive as a consumer.

The New World of the Customer Experience - Not Your Daddy's Call ...

In this webcast, we will talk about how TrialCard's Customer Experience Center has become the focal point of our business - from inbound support for pharmacies, physicians, and patients through teledetailing and whitespace management to insurance verification and marketing research.

Co-pay Programs in the Crosshairs: An Evidence-based Response to Critics

We've heard the continuous drumbeat from payers and PBMs: "Co-pay programs interfere with generic substitution!" "They subvert cost-sharing 'strategies' that payers put in place!" "They increase health care costs!" That's what they say, but what's the real truth? This presentation uses payers' own data to ...